<?xml version="1.0" encoding="UTF-8" ?>
<oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>β-amyloid controls altered Reelin expression and processing in Alzheimer's disease</dc:title>
<dc:creator>Botella-López, Arancha</dc:creator>
<dc:creator>Cuchillo-Ibáñez, Inmaculada</dc:creator>
<dc:creator>Cotrufo, Tiziana</dc:creator>
<dc:creator>Mok, Su San</dc:creator>
<dc:creator>Li, Qiao-Xin</dc:creator>
<dc:creator>Barquero, María Sagrario</dc:creator>
<dc:creator>Dierssen, M.</dc:creator>
<dc:creator>Soriano, Eduardo</dc:creator>
<dc:creator>Sáez-Valero, Javier</dc:creator>
<dc:description>10 p., 5 figures and references.</dc:description>
<dc:description>Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the frontal cortex in adult Down's syndrome (DS), where the extra copy of chromosome 21 leads to overexpression of β-amyloid. In cortical extracts of fetal DS samples we detected increased levels of the full-length Reelin and the 310-kDa fragment. Overexpression of mutant human amyloid precursor protein also led to an increase in levels of Reelin fragments in Tg2576 transgenic mice for human β-amyloid. Finally, in vitro Aβ42 treatment of SH-SY5Y neuroblastoma cells led to increased Reelin levels. An altered pattern of Reelin glycosylation was detected in extracts from the frontal cortex of AD patients and in Aβ42-treated SH-SY5Y cells, supporting the notion that β-amyloid triggers altered Reelin processing. These results provide evidence that Reelin expression and processing is altered in several amyloid conditions.</dc:description>
<dc:description>This work was supported by grants from Ministerio de Ciencia e Innovación (MCI, Grant BFU2008-3980), FIS (Grant 06/0181), Fundació Obra Social Caixa Catalunya, EU-037627-AnEUploidy, and CIBERNED, ISC-III from Spain.</dc:description>
<dc:description>Peer reviewed</dc:description>
<dc:date>2012-09-12T11:18:31Z</dc:date>
<dc:date>2012-09-12T11:18:31Z</dc:date>
<dc:date>2010-03</dc:date>
<dc:type>artículo</dc:type>
<dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
<dc:identifier>Neurobiology of Disease 37(3): 682-691 (2010)</dc:identifier>
<dc:identifier>0969-9961</dc:identifier>
<dc:identifier>http://hdl.handle.net/10261/56174</dc:identifier>
<dc:identifier>10.1016/j.nbd.2009.12.006</dc:identifier>
<dc:language>en</dc:language>
<dc:relation>http://dx.doi.org/10.1016/j.nbd.2009.12.006</dc:relation>
<dc:rights>none</dc:rights>
<dc:publisher>Academic Press</dc:publisher>
</oai_dc:dc>
<?xml version="1.0" encoding="UTF-8" ?>
<resource>
<identifier>http://hdl.handle.net/10261/56174</identifier>
<alternateIdentifiers>
<alternateIdentifier identifierType="DOI">10.1016/j.nbd.2009.12.006</alternateIdentifier>
<alternateIdentifier alternateIdentifierType="DCSIC">58470</alternateIdentifier>
</alternateIdentifiers>
<titles>
<title lang="es_ES">β-amyloid controls altered Reelin expression and processing in Alzheimer's disease</title>
</titles>
<publisher>Academic Press</publisher>
<publicationYear>2010</publicationYear>
<resourceType resourceTypeGeneral="JournalArticle">artículo</resourceType>
<creators>
<creator>
<creatorName>Botella-López, Arancha</creatorName>
</creator>
<creator>
<creatorName>Cuchillo-Ibáñez, Inmaculada</creatorName>
</creator>
<creator>
<creatorName>Cotrufo, Tiziana</creatorName>
</creator>
<creator>
<creatorName>Mok, Su San</creatorName>
</creator>
<creator>
<creatorName>Li, Qiao-Xin</creatorName>
</creator>
<creator>
<creatorName>Barquero, María Sagrario</creatorName>
</creator>
<creator>
<creatorName>Dierssen, M.</creatorName>
</creator>
<creator>
<creatorName>Soriano, Eduardo</creatorName>
</creator>
<creator>
<creatorName>Sáez-Valero, Javier</creatorName>
</creator>
</creators>
<dates>
<date dateType="Issued">2010-03</date>
</dates>
<descriptions>
<description descriptionType="Description">10 p., 5 figures and references.</description>
<description descriptionType="Abstract">Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the frontal cortex in adult Down's syndrome (DS), where the extra copy of chromosome 21 leads to overexpression of β-amyloid. In cortical extracts of fetal DS samples we detected increased levels of the full-length Reelin and the 310-kDa fragment. Overexpression of mutant human amyloid precursor protein also led to an increase in levels of Reelin fragments in Tg2576 transgenic mice for human β-amyloid. Finally, in vitro Aβ42 treatment of SH-SY5Y neuroblastoma cells led to increased Reelin levels. An altered pattern of Reelin glycosylation was detected in extracts from the frontal cortex of AD patients and in Aβ42-treated SH-SY5Y cells, supporting the notion that β-amyloid triggers altered Reelin processing. These results provide evidence that Reelin expression and processing is altered in several amyloid conditions.</description>
</descriptions>
<rightsList>
</rightsList>
<relatedItems>
<relatedItem relationType="IsPublishedIn">
<titles>
<title>Neurobiology of Disease</title>
</titles>
<publicationYear>2010</publicationYear>
<volume>37</volume>
<firstPage>682</firstPage>
<lastPage>691</lastPage>
</relatedItem>
</relatedItems>
</resource>
<?xml version="1.0" encoding="UTF-8" ?>
<d:DIDL schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
<d:DIDLInfo>
<dcterms:created schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2012-09-12T11:18:31Z</dcterms:created>
</d:DIDLInfo>
<d:Item id="hdl_10261_56174">
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<dii:Identifier schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10261/56174</dii:Identifier>
</d:Statement>
</d:Descriptor>
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>β-amyloid controls altered Reelin expression and processing in Alzheimer's disease</dc:title>
<dc:creator>Botella-López, Arancha</dc:creator>
<dc:creator>Cuchillo-Ibáñez, Inmaculada</dc:creator>
<dc:creator>Cotrufo, Tiziana</dc:creator>
<dc:creator>Mok, Su San</dc:creator>
<dc:creator>Li, Qiao-Xin</dc:creator>
<dc:creator>Barquero, María Sagrario</dc:creator>
<dc:creator>Dierssen, M.</dc:creator>
<dc:creator>Soriano, Eduardo</dc:creator>
<dc:creator>Sáez-Valero, Javier</dc:creator>
<dc:description>10 p., 5 figures and references.</dc:description>
<dc:description>Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the frontal cortex in adult Down's syndrome (DS), where the extra copy of chromosome 21 leads to overexpression of β-amyloid. In cortical extracts of fetal DS samples we detected increased levels of the full-length Reelin and the 310-kDa fragment. Overexpression of mutant human amyloid precursor protein also led to an increase in levels of Reelin fragments in Tg2576 transgenic mice for human β-amyloid. Finally, in vitro Aβ42 treatment of SH-SY5Y neuroblastoma cells led to increased Reelin levels. An altered pattern of Reelin glycosylation was detected in extracts from the frontal cortex of AD patients and in Aβ42-treated SH-SY5Y cells, supporting the notion that β-amyloid triggers altered Reelin processing. These results provide evidence that Reelin expression and processing is altered in several amyloid conditions.</dc:description>
<dc:date>2012-09-12T11:18:31Z</dc:date>
<dc:date>2012-09-12T11:18:31Z</dc:date>
<dc:date>2010-03</dc:date>
<dc:type>artículo</dc:type>
<dc:identifier>Neurobiology of Disease 37(3): 682-691 (2010)</dc:identifier>
<dc:identifier>0969-9961</dc:identifier>
<dc:identifier>http://hdl.handle.net/10261/56174</dc:identifier>
<dc:identifier>10.1016/j.nbd.2009.12.006</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>http://dx.doi.org/10.1016/j.nbd.2009.12.006</dc:relation>
<dc:rights>closedAccess</dc:rights>
<dc:publisher>Academic Press</dc:publisher>
</oai_dc:dc>
</d:Statement>
</d:Descriptor>
<d:Component id="10261_56174_1">
</d:Component>
</d:Item>
</d:DIDL>
<?xml version="1.0" encoding="UTF-8" ?>
<dim:dim schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
<dim:field element="contributor" mdschema="dc" qualifier="author">Botella-López, Arancha</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Cuchillo-Ibáñez, Inmaculada</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Cotrufo, Tiziana</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Mok, Su San</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Li, Qiao-Xin</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Barquero, María Sagrario</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Dierssen, M.</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Soriano, Eduardo</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Sáez-Valero, Javier</dim:field>
<dim:field element="date" mdschema="dc" qualifier="accessioned">2012-09-12T11:18:31Z</dim:field>
<dim:field element="date" mdschema="dc" qualifier="available">2012-09-12T11:18:31Z</dim:field>
<dim:field element="date" mdschema="dc" qualifier="issued">2010-03</dim:field>
<dim:field element="identifier" lang="es_ES" mdschema="dc" qualifier="citation">Neurobiology of Disease 37(3): 682-691 (2010)</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="issn">0969-9961</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="uri">http://hdl.handle.net/10261/56174</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="doi">10.1016/j.nbd.2009.12.006</dim:field>
<dim:field element="description" lang="es_ES" mdschema="dc">10 p., 5 figures and references.</dim:field>
<dim:field element="description" lang="es_ES" mdschema="dc" qualifier="abstract">Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the frontal cortex in adult Down's syndrome (DS), where the extra copy of chromosome 21 leads to overexpression of β-amyloid. In cortical extracts of fetal DS samples we detected increased levels of the full-length Reelin and the 310-kDa fragment. Overexpression of mutant human amyloid precursor protein also led to an increase in levels of Reelin fragments in Tg2576 transgenic mice for human β-amyloid. Finally, in vitro Aβ42 treatment of SH-SY5Y neuroblastoma cells led to increased Reelin levels. An altered pattern of Reelin glycosylation was detected in extracts from the frontal cortex of AD patients and in Aβ42-treated SH-SY5Y cells, supporting the notion that β-amyloid triggers altered Reelin processing. These results provide evidence that Reelin expression and processing is altered in several amyloid conditions.</dim:field>
<dim:field element="description" lang="es_ES" mdschema="dc" qualifier="sponsorship">This work was supported by grants from Ministerio de Ciencia e Innovación (MCI, Grant BFU2008-3980), FIS (Grant 06/0181), Fundació Obra Social Caixa Catalunya, EU-037627-AnEUploidy, and CIBERNED, ISC-III from Spain.</dim:field>
<dim:field element="description" lang="es_ES" mdschema="dc" qualifier="peerreviewed">Peer reviewed</dim:field>
<dim:field element="language" lang="es_ES" mdschema="dc" qualifier="iso">eng</dim:field>
<dim:field element="publisher" lang="es_ES" mdschema="dc">Academic Press</dim:field>
<dim:field element="rights" lang="es_ES" mdschema="dc">closedAccess</dim:field>
<dim:field element="title" lang="es_ES" mdschema="dc">β-amyloid controls altered Reelin expression and processing in Alzheimer's disease</dim:field>
<dim:field element="type" lang="es_ES" mdschema="dc">artículo</dim:field>
<dim:field authority="" confidence="-1" element="type" lang="es_ES" mdschema="dc" qualifier="coar">http://purl.org/coar/resource_type/c_6501</dim:field>
<dim:field element="relation" lang="es_ES" mdschema="dc" qualifier="publisherversion">http://dx.doi.org/10.1016/j.nbd.2009.12.006</dim:field>
</dim:dim>
<?xml version="1.0" encoding="UTF-8" ?>
<thesis schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd">
<title>β-amyloid controls altered Reelin expression and processing in Alzheimer's disease</title>
<creator>Botella-López, Arancha</creator>
<creator>Cuchillo-Ibáñez, Inmaculada</creator>
<creator>Cotrufo, Tiziana</creator>
<creator>Mok, Su San</creator>
<creator>Li, Qiao-Xin</creator>
<creator>Barquero, María Sagrario</creator>
<creator>Dierssen, M.</creator>
<creator>Soriano, Eduardo</creator>
<creator>Sáez-Valero, Javier</creator>
<description>10 p., 5 figures and references.</description>
<description>Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the frontal cortex in adult Down's syndrome (DS), where the extra copy of chromosome 21 leads to overexpression of β-amyloid. In cortical extracts of fetal DS samples we detected increased levels of the full-length Reelin and the 310-kDa fragment. Overexpression of mutant human amyloid precursor protein also led to an increase in levels of Reelin fragments in Tg2576 transgenic mice for human β-amyloid. Finally, in vitro Aβ42 treatment of SH-SY5Y neuroblastoma cells led to increased Reelin levels. An altered pattern of Reelin glycosylation was detected in extracts from the frontal cortex of AD patients and in Aβ42-treated SH-SY5Y cells, supporting the notion that β-amyloid triggers altered Reelin processing. These results provide evidence that Reelin expression and processing is altered in several amyloid conditions.</description>
<date>2012-09-12</date>
<date>2012-09-12</date>
<date>2010-03</date>
<type>artículo</type>
<identifier>Neurobiology of Disease 37(3): 682-691 (2010)</identifier>
<identifier>0969-9961</identifier>
<identifier>http://hdl.handle.net/10261/56174</identifier>
<identifier>10.1016/j.nbd.2009.12.006</identifier>
<language>eng</language>
<relation>http://dx.doi.org/10.1016/j.nbd.2009.12.006</relation>
<rights>closedAccess</rights>
<publisher>Academic Press</publisher>
</thesis>
<?xml version="1.0" encoding="UTF-8" ?>
<record schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>00925njm 22002777a 4500</leader>
<datafield ind1=" " ind2=" " tag="042">
<subfield code="a">dc</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Botella-López, Arancha</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Cuchillo-Ibáñez, Inmaculada</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Cotrufo, Tiziana</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Mok, Su San</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Li, Qiao-Xin</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Barquero, María Sagrario</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Dierssen, M.</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Soriano, Eduardo</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Sáez-Valero, Javier</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="260">
<subfield code="c">2010-03</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="520">
<subfield code="a">Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the frontal cortex in adult Down's syndrome (DS), where the extra copy of chromosome 21 leads to overexpression of β-amyloid. In cortical extracts of fetal DS samples we detected increased levels of the full-length Reelin and the 310-kDa fragment. Overexpression of mutant human amyloid precursor protein also led to an increase in levels of Reelin fragments in Tg2576 transgenic mice for human β-amyloid. Finally, in vitro Aβ42 treatment of SH-SY5Y neuroblastoma cells led to increased Reelin levels. An altered pattern of Reelin glycosylation was detected in extracts from the frontal cortex of AD patients and in Aβ42-treated SH-SY5Y cells, supporting the notion that β-amyloid triggers altered Reelin processing. These results provide evidence that Reelin expression and processing is altered in several amyloid conditions.</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">Neurobiology of Disease 37(3): 682-691 (2010)</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">0969-9961</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">http://hdl.handle.net/10261/56174</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">10.1016/j.nbd.2009.12.006</subfield>
</datafield>
<datafield ind1="0" ind2="0" tag="245">
<subfield code="a">β-amyloid controls altered Reelin expression and processing in Alzheimer's disease</subfield>
</datafield>
</record>
<?xml version="1.0" encoding="UTF-8" ?>
<mets ID=" DSpace_ITEM_10261-56174" OBJID=" hdl:10261/56174" PROFILE="DSpace METS SIP Profile 1.0" TYPE="DSpace ITEM" schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd">
<metsHdr CREATEDATE="2022-08-19T10:13:05Z">
<agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
<name>DIGITAL.CSIC</name>
</agent>
</metsHdr>
<dmdSec ID="DMD_10261_56174">
<mdWrap MDTYPE="MODS">
<xmlData schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Botella-López, Arancha</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Cuchillo-Ibáñez, Inmaculada</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Cotrufo, Tiziana</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Mok, Su San</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Li, Qiao-Xin</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Barquero, María Sagrario</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Dierssen, M.</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Soriano, Eduardo</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Sáez-Valero, Javier</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2012-09-12T11:18:31Z</mods:dateAccessioned>
</mods:extension>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2012-09-12T11:18:31Z</mods:dateAvailable>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2010-03</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="citation">Neurobiology of Disease 37(3): 682-691 (2010)</mods:identifier>
<mods:identifier type="issn">0969-9961</mods:identifier>
<mods:identifier type="uri">http://hdl.handle.net/10261/56174</mods:identifier>
<mods:identifier type="doi">10.1016/j.nbd.2009.12.006</mods:identifier>
<mods:abstract>Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the frontal cortex in adult Down's syndrome (DS), where the extra copy of chromosome 21 leads to overexpression of β-amyloid. In cortical extracts of fetal DS samples we detected increased levels of the full-length Reelin and the 310-kDa fragment. Overexpression of mutant human amyloid precursor protein also led to an increase in levels of Reelin fragments in Tg2576 transgenic mice for human β-amyloid. Finally, in vitro Aβ42 treatment of SH-SY5Y neuroblastoma cells led to increased Reelin levels. An altered pattern of Reelin glycosylation was detected in extracts from the frontal cortex of AD patients and in Aβ42-treated SH-SY5Y cells, supporting the notion that β-amyloid triggers altered Reelin processing. These results provide evidence that Reelin expression and processing is altered in several amyloid conditions.</mods:abstract>
<mods:language>
<mods:languageTerm authority="rfc3066">eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">closedAccess</mods:accessCondition>
<mods:titleInfo>
<mods:title>β-amyloid controls altered Reelin expression and processing in Alzheimer's disease</mods:title>
</mods:titleInfo>
<mods:genre>artículo</mods:genre>
</mods:mods>
</xmlData>
</mdWrap>
</dmdSec>
<amdSec ID="TMD_10261_56174">
<rightsMD ID="RIG_10261_56174">
<mdWrap MDTYPE="OTHER" MIMETYPE="text/plain" OTHERMDTYPE="DSpaceDepositLicense">
<binData>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</binData>
</mdWrap>
</rightsMD>
</amdSec>
<amdSec ID="FO_10261_56174_1">
<techMD ID="TECH_O_10261_56174_1">
<mdWrap MDTYPE="PREMIS">
<xmlData schemaLocation="http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd">
<premis:premis>
<premis:object>
<premis:objectIdentifier>
<premis:objectIdentifierType>URL</premis:objectIdentifierType>
<premis:objectIdentifierValue>https://digital.csic.es/bitstream/10261/56174/1/restringido.pdf</premis:objectIdentifierValue>
</premis:objectIdentifier>
<premis:objectCategory>File</premis:objectCategory>
<premis:objectCharacteristics>
<premis:fixity>
<premis:messageDigestAlgorithm>MD5</premis:messageDigestAlgorithm>
<premis:messageDigest>9604f11744191f2c5a9b7182e2d65ffa</premis:messageDigest>
</premis:fixity>
<premis:size>22195</premis:size>
<premis:format>
<premis:formatDesignation>
<premis:formatName>application/pdf</premis:formatName>
</premis:formatDesignation>
</premis:format>
</premis:objectCharacteristics>
<premis:originalName>restringido.pdf</premis:originalName>
</premis:object>
</premis:premis>
</xmlData>
</mdWrap>
</techMD>
</amdSec>
<amdSec ID="FT_10261_56174_4">
<techMD ID="TECH_T_10261_56174_4">
<mdWrap MDTYPE="PREMIS">
<xmlData schemaLocation="http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd">
<premis:premis>
<premis:object>
<premis:objectIdentifier>
<premis:objectIdentifierType>URL</premis:objectIdentifierType>
<premis:objectIdentifierValue>https://digital.csic.es/bitstream/10261/56174/4/restringido.pdf.txt</premis:objectIdentifierValue>
</premis:objectIdentifier>
<premis:objectCategory>File</premis:objectCategory>
<premis:objectCharacteristics>
<premis:fixity>
<premis:messageDigestAlgorithm>MD5</premis:messageDigestAlgorithm>
<premis:messageDigest>d3c472b48241e68827e4270f6edb356a</premis:messageDigest>
</premis:fixity>
<premis:size>366</premis:size>
<premis:format>
<premis:formatDesignation>
<premis:formatName>text/plain</premis:formatName>
</premis:formatDesignation>
</premis:format>
</premis:objectCharacteristics>
<premis:originalName>restringido.pdf.txt</premis:originalName>
</premis:object>
</premis:premis>
</xmlData>
</mdWrap>
</techMD>
</amdSec>
<fileSec>
<fileGrp USE="ORIGINAL">
<file ADMID="FO_10261_56174_1" CHECKSUM="9604f11744191f2c5a9b7182e2d65ffa" CHECKSUMTYPE="MD5" GROUPID="GROUP_BITSTREAM_10261_56174_1" ID="BITSTREAM_ORIGINAL_10261_56174_1" MIMETYPE="application/pdf" SEQ="1" SIZE="22195">
</file>
</fileGrp>
<fileGrp USE="TEXT">
<file ADMID="FT_10261_56174_4" CHECKSUM="d3c472b48241e68827e4270f6edb356a" CHECKSUMTYPE="MD5" GROUPID="GROUP_BITSTREAM_10261_56174_4" ID="BITSTREAM_TEXT_10261_56174_4" MIMETYPE="text/plain" SEQ="4" SIZE="366">
</file>
</fileGrp>
</fileSec>
<structMap LABEL="DSpace Object" TYPE="LOGICAL">
<div ADMID="DMD_10261_56174" TYPE="DSpace Object Contents">
<div TYPE="DSpace BITSTREAM">
</div>
</div>
</structMap>
</mets>
<?xml version="1.0" encoding="UTF-8" ?>
<mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Botella-López, Arancha</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Cuchillo-Ibáñez, Inmaculada</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Cotrufo, Tiziana</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Mok, Su San</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Li, Qiao-Xin</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Barquero, María Sagrario</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Dierssen, M.</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Soriano, Eduardo</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Sáez-Valero, Javier</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2012-09-12T11:18:31Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2012-09-12T11:18:31Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2010-03</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="citation">Neurobiology of Disease 37(3): 682-691 (2010)</mods:identifier>
<mods:identifier type="issn">0969-9961</mods:identifier>
<mods:identifier type="uri">http://hdl.handle.net/10261/56174</mods:identifier>
<mods:identifier type="doi">10.1016/j.nbd.2009.12.006</mods:identifier>
<mods:abstract>Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the frontal cortex in adult Down's syndrome (DS), where the extra copy of chromosome 21 leads to overexpression of β-amyloid. In cortical extracts of fetal DS samples we detected increased levels of the full-length Reelin and the 310-kDa fragment. Overexpression of mutant human amyloid precursor protein also led to an increase in levels of Reelin fragments in Tg2576 transgenic mice for human β-amyloid. Finally, in vitro Aβ42 treatment of SH-SY5Y neuroblastoma cells led to increased Reelin levels. An altered pattern of Reelin glycosylation was detected in extracts from the frontal cortex of AD patients and in Aβ42-treated SH-SY5Y cells, supporting the notion that β-amyloid triggers altered Reelin processing. These results provide evidence that Reelin expression and processing is altered in several amyloid conditions.</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">closedAccess</mods:accessCondition>
<mods:titleInfo>
<mods:title>β-amyloid controls altered Reelin expression and processing in Alzheimer's disease</mods:title>
</mods:titleInfo>
<mods:genre>artículo</mods:genre>
</mods:mods>
<?xml version="1.0" encoding="UTF-8" ?>
<oai_cerif:Publication id="10261/56174">
<oai_cerif:Type>http://purl.org/coar/resource_type/c_18cf</oai_cerif:Type>
<oai_cerif:Title lang="en">β-amyloid controls altered Reelin expression and processing in Alzheimer's disease</oai_cerif:Title>
<oai_cerif:PublicationDate>2010-03</oai_cerif:PublicationDate>
<oai_cerif:DOI>10.1016/j.nbd.2009.12.006</oai_cerif:DOI>
<oai_cerif:Handle>10261/56174</oai_cerif:Handle>
<oai_cerif:URN>http://hdl.handle.net/10261/56174</oai_cerif:URN>
<oai_cerif:Authors>
<oai_cerif:Author>
<oai_cerif:DisplayName>Botella-López, Arancha</oai_cerif:DisplayName>
</oai_cerif:Author>
<oai_cerif:Author>
<oai_cerif:DisplayName>Cuchillo-Ibáñez, Inmaculada</oai_cerif:DisplayName>
</oai_cerif:Author>
<oai_cerif:Author>
<oai_cerif:DisplayName>Cotrufo, Tiziana</oai_cerif:DisplayName>
</oai_cerif:Author>
<oai_cerif:Author>
<oai_cerif:DisplayName>Mok, Su San</oai_cerif:DisplayName>
</oai_cerif:Author>
<oai_cerif:Author>
<oai_cerif:DisplayName>Li, Qiao-Xin</oai_cerif:DisplayName>
</oai_cerif:Author>
<oai_cerif:Author>
<oai_cerif:DisplayName>Barquero, María Sagrario</oai_cerif:DisplayName>
</oai_cerif:Author>
<oai_cerif:Author>
<oai_cerif:DisplayName>Dierssen, M.</oai_cerif:DisplayName>
</oai_cerif:Author>
<oai_cerif:Author>
<oai_cerif:DisplayName>Soriano, Eduardo</oai_cerif:DisplayName>
</oai_cerif:Author>
<oai_cerif:Author>
<oai_cerif:DisplayName>Sáez-Valero, Javier</oai_cerif:DisplayName>
</oai_cerif:Author>
</oai_cerif:Authors>
<oai_cerif:Publishers>
<oai_cerif:Publisher>
<oai_cerif:DisplayName>Academic Press</oai_cerif:DisplayName>
</oai_cerif:Publisher>
</oai_cerif:Publishers>
<oai_cerif:Abstract lang="en">Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the frontal cortex in adult Down's syndrome (DS), where the extra copy of chromosome 21 leads to overexpression of β-amyloid. In cortical extracts of fetal DS samples we detected increased levels of the full-length Reelin and the 310-kDa fragment. Overexpression of mutant human amyloid precursor protein also led to an increase in levels of Reelin fragments in Tg2576 transgenic mice for human β-amyloid. Finally, in vitro Aβ42 treatment of SH-SY5Y neuroblastoma cells led to increased Reelin levels. An altered pattern of Reelin glycosylation was detected in extracts from the frontal cortex of AD patients and in Aβ42-treated SH-SY5Y cells, supporting the notion that β-amyloid triggers altered Reelin processing. These results provide evidence that Reelin expression and processing is altered in several amyloid conditions.</oai_cerif:Abstract>
<ns4:Access>http://purl.org/coar/access_right/c_14cb</ns4:Access>
</oai_cerif:Publication>
<?xml version="1.0" encoding="UTF-8" ?>
<atom:entry schemaLocation="http://www.w3.org/2005/Atom http://www.kbcafe.com/rss/atom.xsd.xml">
<atom:id>http://hdl.handle.net/10261/56174/ore.xml</atom:id>
<atom:published>2012-09-12T11:18:31Z</atom:published>
<atom:updated>2012-09-12T11:18:31Z</atom:updated>
<atom:source>
<atom:generator>DIGITAL.CSIC</atom:generator>
</atom:source>
<atom:title>β-amyloid controls altered Reelin expression and processing in Alzheimer's disease</atom:title>
<atom:author>
<atom:name>Botella-López, Arancha</atom:name>
</atom:author>
<atom:author>
<atom:name>Cuchillo-Ibáñez, Inmaculada</atom:name>
</atom:author>
<atom:author>
<atom:name>Cotrufo, Tiziana</atom:name>
</atom:author>
<atom:author>
<atom:name>Mok, Su San</atom:name>
</atom:author>
<atom:author>
<atom:name>Li, Qiao-Xin</atom:name>
</atom:author>
<atom:author>
<atom:name>Barquero, María Sagrario</atom:name>
</atom:author>
<atom:author>
<atom:name>Dierssen, M.</atom:name>
</atom:author>
<atom:author>
<atom:name>Soriano, Eduardo</atom:name>
</atom:author>
<atom:author>
<atom:name>Sáez-Valero, Javier</atom:name>
</atom:author>
<oreatom:triples>
<rdf:Description about="http://hdl.handle.net/10261/56174/ore.xml#atom">
<dcterms:modified>2012-09-12T11:18:31Z</dcterms:modified>
</rdf:Description>
<rdf:Description about="https://digital.csic.es/bitstream/10261/56174/1/restringido.pdf">
<dcterms:description>ORIGINAL</dcterms:description>
</rdf:Description>
<rdf:Description about="https://digital.csic.es/bitstream/10261/56174/2/license.txt">
<dcterms:description>LICENSE</dcterms:description>
</rdf:Description>
<rdf:Description about="https://digital.csic.es/bitstream/10261/56174/3/restringido.pdf.jpg">
<dcterms:description>THUMBNAIL</dcterms:description>
</rdf:Description>
<rdf:Description about="https://digital.csic.es/bitstream/10261/56174/4/restringido.pdf.txt">
<dcterms:description>TEXT</dcterms:description>
</rdf:Description>
</oreatom:triples>
</atom:entry>
<?xml version="1.0" encoding="UTF-8" ?>
<qdc:qualifieddc schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
<dc:title>β-amyloid controls altered Reelin expression and processing in Alzheimer's disease</dc:title>
<dc:creator>Botella-López, Arancha</dc:creator>
<dc:creator>Cuchillo-Ibáñez, Inmaculada</dc:creator>
<dc:creator>Cotrufo, Tiziana</dc:creator>
<dc:creator>Mok, Su San</dc:creator>
<dc:creator>Li, Qiao-Xin</dc:creator>
<dc:creator>Barquero, María Sagrario</dc:creator>
<dc:creator>Dierssen, M.</dc:creator>
<dc:creator>Soriano, Eduardo</dc:creator>
<dc:creator>Sáez-Valero, Javier</dc:creator>
<dcterms:abstract>Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the frontal cortex in adult Down's syndrome (DS), where the extra copy of chromosome 21 leads to overexpression of β-amyloid. In cortical extracts of fetal DS samples we detected increased levels of the full-length Reelin and the 310-kDa fragment. Overexpression of mutant human amyloid precursor protein also led to an increase in levels of Reelin fragments in Tg2576 transgenic mice for human β-amyloid. Finally, in vitro Aβ42 treatment of SH-SY5Y neuroblastoma cells led to increased Reelin levels. An altered pattern of Reelin glycosylation was detected in extracts from the frontal cortex of AD patients and in Aβ42-treated SH-SY5Y cells, supporting the notion that β-amyloid triggers altered Reelin processing. These results provide evidence that Reelin expression and processing is altered in several amyloid conditions.</dcterms:abstract>
<dcterms:dateAccepted>2012-09-12T11:18:31Z</dcterms:dateAccepted>
<dcterms:available>2012-09-12T11:18:31Z</dcterms:available>
<dcterms:created>2012-09-12T11:18:31Z</dcterms:created>
<dcterms:issued>2010-03</dcterms:issued>
<dc:type>artículo</dc:type>
<dc:identifier>Neurobiology of Disease 37(3): 682-691 (2010)</dc:identifier>
<dc:identifier>0969-9961</dc:identifier>
<dc:identifier>http://hdl.handle.net/10261/56174</dc:identifier>
<dc:identifier>10.1016/j.nbd.2009.12.006</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>http://dx.doi.org/10.1016/j.nbd.2009.12.006</dc:relation>
<dc:rights>closedAccess</dc:rights>
<dc:publisher>Academic Press</dc:publisher>
</qdc:qualifieddc>
<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
<ow:Publication about="oai:digital.csic.es:10261/56174">
<dc:title>β-amyloid controls altered Reelin expression and processing in Alzheimer's disease</dc:title>
<dc:creator>Botella-López, Arancha</dc:creator>
<dc:creator>Cuchillo-Ibáñez, Inmaculada</dc:creator>
<dc:creator>Cotrufo, Tiziana</dc:creator>
<dc:creator>Mok, Su San</dc:creator>
<dc:creator>Li, Qiao-Xin</dc:creator>
<dc:creator>Barquero, María Sagrario</dc:creator>
<dc:creator>Dierssen, M.</dc:creator>
<dc:creator>Soriano, Eduardo</dc:creator>
<dc:creator>Sáez-Valero, Javier</dc:creator>
<dc:description>10 p., 5 figures and references.</dc:description>
<dc:description>Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the frontal cortex in adult Down's syndrome (DS), where the extra copy of chromosome 21 leads to overexpression of β-amyloid. In cortical extracts of fetal DS samples we detected increased levels of the full-length Reelin and the 310-kDa fragment. Overexpression of mutant human amyloid precursor protein also led to an increase in levels of Reelin fragments in Tg2576 transgenic mice for human β-amyloid. Finally, in vitro Aβ42 treatment of SH-SY5Y neuroblastoma cells led to increased Reelin levels. An altered pattern of Reelin glycosylation was detected in extracts from the frontal cortex of AD patients and in Aβ42-treated SH-SY5Y cells, supporting the notion that β-amyloid triggers altered Reelin processing. These results provide evidence that Reelin expression and processing is altered in several amyloid conditions.</dc:description>
<dc:date>2012-09-12T11:18:31Z</dc:date>
<dc:date>2012-09-12T11:18:31Z</dc:date>
<dc:date>2010-03</dc:date>
<dc:type>artículo</dc:type>
<dc:identifier>Neurobiology of Disease 37(3): 682-691 (2010)</dc:identifier>
<dc:identifier>0969-9961</dc:identifier>
<dc:identifier>http://hdl.handle.net/10261/56174</dc:identifier>
<dc:identifier>10.1016/j.nbd.2009.12.006</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>http://dx.doi.org/10.1016/j.nbd.2009.12.006</dc:relation>
<dc:rights>closedAccess</dc:rights>
<dc:publisher>Academic Press</dc:publisher>
</ow:Publication>
</rdf:RDF>